Hims and Hers Health Inc vs PayPal Holdings, Inc. — how do they compare? Hims and Hers Health Inc trades at $29.27 (market cap $6.55B), while PayPal Holdings, Inc. trades at $55.26 (market cap $47.07B). The key difference: PayPal Holdings, Inc. is far larger — about 7.2× Hims and Hers Health Inc's market cap, and PayPal Holdings, Inc. pays a 1.02% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and PayPal Holdings, Inc. for 106 Days on average.
| HIMS | PYPL | |
|---|---|---|
Market Cap | $6.55B | $47.07B |
Volume | 14,842,814 | 13,860,099 |
Sector | Health | Financials |
52-Week High | $62.76 | $75.75 |
52-Week Low | $14.52 | $39.08 |
Typical Hold Time | 21 Days | 106 Days |
Enterprise Value | $7.25B | $49.21B |
Dividend Yield | — | 1.02% |
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health (HIMS) trades at $29.38, down 0.54% on the day, amid a bearish technical signal and mixed earnings history. The company reported revenue of $2.35 billion in 2025 with a net income of $128.37 million, but 2026 projections show a net loss of $142 million. Valuation ratios are elevated with a P/E of 57.14 and EV/EBITDA of 205.86. Recent news highlights multiple securities class action lawsuits filed against the company, creating investor uncertainty.
The outlook is cautious due to profitability concerns and legal risks. Analyst consensus is a Hold with a $32.17 price target, suggesting limited upside. Key risks include ongoing litigation, negative profit margins, and high valuation multiples. Investment appeal hinges on the company's ability to return to profitability and navigate regulatory challenges.
PayPal (PYPL) trades at $55.47, up 0.95% today, with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals with a P/E of 10.4, net income margin of 14.36%, and consistent revenue growth from $33.17B in 2025 to $34.1B projected for 2026. Recent positive developments include a Meta partnership for AI-powered checkout and three consecutive quarterly earnings beats.
PYPL presents a compelling value opportunity with attractive valuation multiples and solid profitability, though investors face risks from checkout competition and slowing growth. Analyst consensus leans cautious with 60% hold ratings, but the $56.41 price target suggests modest upside potential from current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →